BCART

Biocartis Group NV (BCART)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:BCART
DataOraFonteTitoloSimboloCompagnia
10/01/202423:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings)EU:BCARTBiocartis Group NV
10/01/202423:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings)EU:BCARTBiocartis Group NV
22/11/202310:00GlobeNewswire Inc.Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansionEU:BCARTBiocartis Group NV
13/11/202307:00GlobeNewswire Inc.Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual MeetingEU:BCARTBiocartis Group NV
31/10/202315:55GlobeNewswire Inc.Press release Biocartis Group NV: Announcement regarding Enforcement by Secured CreditorsEU:BCARTBiocartis Group NV
20/10/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO)EU:BCARTBiocartis Group NV
16/10/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer PortfolioEU:BCARTBiocartis Group NV
12/10/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations KitEU:BCARTBiocartis Group NV
03/10/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
26/09/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalizationEU:BCARTBiocartis Group NV
26/09/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding companyEU:BCARTBiocartis Group NV
21/09/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023EU:BCARTBiocartis Group NV
28/08/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leadersEU:BCARTBiocartis Group NV
24/08/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023EU:BCARTBiocartis Group NV
10/08/202307:00GlobeNewswire Inc.Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ PlatformEU:BCARTBiocartis Group NV
18/07/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service DeliveryEU:BCARTBiocartis Group NV
30/06/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of Outstanding Voting SecuritiesEU:BCARTBiocartis Group NV
20/06/202317:40GlobeNewswire Inc.Press release Biocartis Group NV: Disclosure of transparency notificationEU:BCARTBiocartis Group NV
15/06/202317:15GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction programEU:BCARTBiocartis Group NV
05/06/202317:40GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces resignation CFOEU:BCARTBiocartis Group NV
12/05/202317:40GlobeNewswire Inc.Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023EU:BCARTBiocartis Group NV
09/05/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer TestEU:BCARTBiocartis Group NV
20/04/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023EU:BCARTBiocartis Group NV
11/04/202322:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEOEU:BCARTBiocartis Group NV
11/04/202307:01GlobeNewswire Inc.Press release Biocartis Group NV: Invitation to the Annual Shareholders’ MeetingEU:BCARTBiocartis Group NV
11/04/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual ReportEU:BCARTBiocartis Group NV
04/04/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platformEU:BCARTBiocartis Group NV
29/03/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023EU:BCARTBiocartis Group NV
02/03/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI TestEU:BCARTBiocartis Group NV
24/02/202307:00GlobeNewswire Inc.Press release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option PlansEU:BCARTBiocartis Group NV
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:EU:BCART
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network